Dr Reddy’s Enters Indian Biosimilar Immuno-Oncology Market
The story in brief
Dr Reddy’s Laboratories launched Nivorz, a biosimilar to Opdivo, in India. The drug, developed in-house in Hyderabad, is approved for 12 cancer types. It aims to expand access to cancer treatments in the country.